These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9522542)

  • 41. Noncompliance in schizophrenia.
    Babiker IE
    Psychiatr Dev; 1986; 4(4):329-37. PubMed ID: 2883650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The (new) definition of compliance].
    Arolt V
    Krankenpfl J; 2005; 43(7-10):214-5. PubMed ID: 16515287
    [No Abstract]   [Full Text] [Related]  

  • 43. Exploring the complexity of compliance in schizophrenia.
    Pinikahana J; Happell B; Taylor M; Keks NA
    Issues Ment Health Nurs; 2002; 23(5):513-28. PubMed ID: 12079602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia.
    Mori K; Nagao M; Yamashita H; Morinobu S; Yamawaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):659-65. PubMed ID: 15276691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Education groups in neuroleptic treatment of schizophrenic patients].
    Gaillard P; Degiovanni A; Parrot F
    Ann Med Psychol (Paris); 1993 Apr; 151(4):340-2. PubMed ID: 7904433
    [No Abstract]   [Full Text] [Related]  

  • 46. Non-compliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors.
    Agarwal MR; Sharma VK; Kishore Kumar KV; Lowe D
    Int J Soc Psychiatry; 1998; 44(2):92-106. PubMed ID: 9675629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topiramate for refractory schizophrenia.
    Millson RC; Owen JA; Lorberg GW; Tackaberry L
    Am J Psychiatry; 2002 Apr; 159(4):675. PubMed ID: 11925318
    [No Abstract]   [Full Text] [Related]  

  • 48. Change in "overinclusive" thinking of schizophrenic patients is related to plasma phenothiazine concentration.
    Phillipson OT; Baker J; Williams M
    Adv Biochem Psychopharmacol; 1980; 24():591-7. PubMed ID: 6105805
    [No Abstract]   [Full Text] [Related]  

  • 49. Hospital vs. community.
    Stastny P; Perlick D
    Hosp Community Psychiatry; 1993 May; 44(5):498-500. PubMed ID: 8099563
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of buspirone in seven schizophrenic subjects.
    Brody D; Adler LA; Kim T; Angrist B; Rotrosen J
    J Clin Psychopharmacol; 1990 Feb; 10(1):68-9. PubMed ID: 1968473
    [No Abstract]   [Full Text] [Related]  

  • 51. [Non-compliance and lack of indications for depot treatment as reasons for exclusion from adequate prevention of recurrence].
    Jakobitsch A; Haug HJ; Greger J; Osterheide M; Pach J; Sprenger R; Tegeler J; Budde G
    Psychiatr Prax; 1996 Sep; 23(5):236-9. PubMed ID: 8992517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obesity as a risk factor for antipsychotic noncompliance.
    Weiden PJ; Mackell JA; McDonnell DD
    Schizophr Res; 2004 Jan; 66(1):51-7. PubMed ID: 14693352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term illness and patterns of medicine taking: are people with schizophrenia a unique group?
    Marland GR; Cash K
    J Psychiatr Ment Health Nurs; 2001 Jun; 8(3):197-204. PubMed ID: 11882128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variables.
    Acosta FJ; Bosch E; Sarmiento G; Juanes N; Caballero-Hidalgo A; Mayans T
    Schizophr Res; 2009 Feb; 107(2-3):213-7. PubMed ID: 18849150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the factors interfering with drug treatment compliance among Brazilian patients with schizophrenia.
    Rosa MA; Marcolin MA; Elkis H
    Braz J Psychiatry; 2005 Sep; 27(3):178-84. PubMed ID: 16224604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Research in schizophrenia and the discontinuation of antipsychotic medications.
    Wyatt RJ
    Schizophr Bull; 1997; 23(1):3-9. PubMed ID: 9050108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Violent behavior among schizophrenic patients.
    Graham LA; Thienhaus OJ; Somoya E
    Am J Psychiatry; 1990 Oct; 147(10):1383-5. PubMed ID: 1975992
    [No Abstract]   [Full Text] [Related]  

  • 58. Is the treatment worse than the cure? Attitudes toward medications among persons with severe mental illness.
    Van Dongen CJ
    J Psychosoc Nurs Ment Health Serv; 1997 Mar; 35(3):21-5. PubMed ID: 9076705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The board-and-care home: does it deserve a bad press?
    van Putten T; Spar JE
    Hosp Community Psychiatry; 1979 Jul; 30(7):461-4. PubMed ID: 36335
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insight and moderating variables.
    Kingsbury SJ; Yi D
    Psychiatr Serv; 2001 Mar; 52(3):387-8. PubMed ID: 11239115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.